This was achieved in July 1964 by Neil McIntyre, a gastroenterologist in training with Sherlock entrusted with Samols' RIA laboratory in his absence
#GLP1 #MetabolicHealth #WeightManagement #Nutraceuticals #BotanicalExtracts #GreenCoffeeBean #ChlorogenicAcid #NaturalAlternatives #ObesityManagement #SupplementScience #DrugDiscontinuation #SustainableWeightLoss #EvidenceBasedNutrition #ProductDevelopment #FormulationScience #PreventiveNutrition #MetabolicSupport #FunctionalIngredients #ClinicalNutrition #PostGLP1 #WeightRegain #NutraceuticalInnovation #PharmaTransition #HerbalMedicine #WellnessScience To view or add a comment, sign in New Clinical on High-Dose Safety Profile for Ashwagandha Root Extract A recent prospective, non-comparative clinical trial published in Frontiers in Nutrition evaluated the safety and tolerability of a standardized Ashwagandha (Withania somnifera) root extract (KSM-66 Ashwagandha) at a high dose of 2,000 mg/day over a 12-week period
The combination of female sex, rapid weight loss, and GLP-1 use means right-upper-quadrant pain should prompt evaluation rather than self-management
The product presentation and professionalism exceeded my expectations
However, as Mounjaro continues to gain market approval and adoption, its accessibility is expected to improve over time, making it more widely available to those seeking this weight management solution
This product is not a drug, food, or cosmetic and may not be misbranded, misused or mis-labled as a drug, food or cosmetic
